Showing results (631-640 of 651) with videos related to
Sort By:
Pageof 66
Nature Cancer|May 29, 2023
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activityMorgane Boulch, Marine Cazaux, Alexis Cuffel, et al.Nature Cancer|March 11, 2026
Diagnostic accuracy, fairness and clinical implementation of AI for breast cancer screening: results of multicenter retrospective and prospective technical feasibility studiesChristopher J Kelly, Marc Wilson, Lucy M Warren, et al.Nature Cancer|February 20, 2026
Eythrocyte-anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trialXiaoqian Nie, Yuehua Liu, Xingyun Yao, et al.Nature Cancer|March 5, 2026
CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-offSi-Cong Ma, Zi-Xuan Rong, Zi-Peng Xu, et al.Nature Cancer|February 19, 2026
Setting higher standards for reports of microbial species in human cancersSteven L Salzberg, Minghao Chia, Alfred Tay, et al.Nature Cancer|February 19, 2026
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detectionYong Zeng, Dor D Abelman, Althaf Singhawansa, et al.Nature Cancer|February 27, 2026
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trialYang Gao, Jie Li, Hangyu Zhang, et al.Nature Cancer|May 1, 2026
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trialIgnacio Melero, Bernhard Reis, Corinne Rusterholz, et al.Nature Cancer|April 28, 2026
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancerChengyi Li, Fang Ke, Hongyi Zhao, et al.Nature Cancer|March 26, 2026
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphomaFelix Czernilofsky, Anna Mathioudaki, Lea Jopp-Saile, et al.Pageof 66